Cargando…
N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
BACKGROUND: Paracrine disruption of growth factors in women with polycystic ovarian syndrome (PCOS) results in production of low quality oocyte, especially following ovulation induction. The aim of this study was to investigate the effects of metformin (MET), N-acetylcysteine (NAC) and their combina...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641458/ https://www.ncbi.nlm.nih.gov/pubmed/29043702 http://dx.doi.org/10.22074/ijfs.2018.5142 |
_version_ | 1783271229296214016 |
---|---|
author | Cheraghi, Ebrahim Soleimani Mehranjani, Malek Shariatzadeh, Seyed Mohammad Ali Nasr Esfahani, Mohammad Hossein Alani, Behrang |
author_facet | Cheraghi, Ebrahim Soleimani Mehranjani, Malek Shariatzadeh, Seyed Mohammad Ali Nasr Esfahani, Mohammad Hossein Alani, Behrang |
author_sort | Cheraghi, Ebrahim |
collection | PubMed |
description | BACKGROUND: Paracrine disruption of growth factors in women with polycystic ovarian syndrome (PCOS) results in production of low quality oocyte, especially following ovulation induction. The aim of this study was to investigate the effects of metformin (MET), N-acetylcysteine (NAC) and their combination on the hormonal levels and expres- sion profile of GDF-9, BMP-15 and c-kit, as hallmarks of oocyte quality, in PCOS patients. MATERIALS AND METHODS: This prospective randomized, double-blind, placebo controlled trial aims to study the effects of MET, NAC and their combination (MET+NAC) on expression of GDF-9, BMP-15 and c-kit mRNA in oocytes [10 at the germinal vesicle (GV) stage, 10 at the MI stage, and 10 at the MII stage from per group] derived following ovulation induction in PCOS. Treatment was carried out for six weeks, starting on the third day of previous cycle until oocyte aspiration. The expression of GDF9, BMP15 and c-kit were determined by quantitative real time polymerase chain reaction (RT-qPCR) and western blot analysis. Data were analyzed with one-way ANOVA. RESULTS: The follicular fluid (FF) level of c-kit protein significantly decreased in the NAC group compared to the other groups. Significant correlations were observed between the FF soluble c-kit protein with FF volume, androstenedione and estradiol. The GDF-9 expression in unfertilized mature oocytes were significantly higher in the NAC group com- pared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups. The c-kit expression in unfertilized mature oocytes were significantly lower in the NAC group compared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups (Registration number: IRCT201204159476N1). CONCLUSION: We concluded that NAC can improve the quality of oocytes in PCOS. |
format | Online Article Text |
id | pubmed-5641458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Royan Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-56414582018-01-01 N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome Cheraghi, Ebrahim Soleimani Mehranjani, Malek Shariatzadeh, Seyed Mohammad Ali Nasr Esfahani, Mohammad Hossein Alani, Behrang Int J Fertil Steril Original Article BACKGROUND: Paracrine disruption of growth factors in women with polycystic ovarian syndrome (PCOS) results in production of low quality oocyte, especially following ovulation induction. The aim of this study was to investigate the effects of metformin (MET), N-acetylcysteine (NAC) and their combination on the hormonal levels and expres- sion profile of GDF-9, BMP-15 and c-kit, as hallmarks of oocyte quality, in PCOS patients. MATERIALS AND METHODS: This prospective randomized, double-blind, placebo controlled trial aims to study the effects of MET, NAC and their combination (MET+NAC) on expression of GDF-9, BMP-15 and c-kit mRNA in oocytes [10 at the germinal vesicle (GV) stage, 10 at the MI stage, and 10 at the MII stage from per group] derived following ovulation induction in PCOS. Treatment was carried out for six weeks, starting on the third day of previous cycle until oocyte aspiration. The expression of GDF9, BMP15 and c-kit were determined by quantitative real time polymerase chain reaction (RT-qPCR) and western blot analysis. Data were analyzed with one-way ANOVA. RESULTS: The follicular fluid (FF) level of c-kit protein significantly decreased in the NAC group compared to the other groups. Significant correlations were observed between the FF soluble c-kit protein with FF volume, androstenedione and estradiol. The GDF-9 expression in unfertilized mature oocytes were significantly higher in the NAC group com- pared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups. The c-kit expression in unfertilized mature oocytes were significantly lower in the NAC group compared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups (Registration number: IRCT201204159476N1). CONCLUSION: We concluded that NAC can improve the quality of oocytes in PCOS. Royan Institute 2018 2017-10-14 /pmc/articles/PMC5641458/ /pubmed/29043702 http://dx.doi.org/10.22074/ijfs.2018.5142 Text en Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Cheraghi, Ebrahim Soleimani Mehranjani, Malek Shariatzadeh, Seyed Mohammad Ali Nasr Esfahani, Mohammad Hossein Alani, Behrang N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome |
title | N-Acetylcysteine Compared to Metformin, Improves The
Expression Profile of Growth Differentiation Factor-9 and
Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients
with Polycystic Ovarian Syndrome |
title_full | N-Acetylcysteine Compared to Metformin, Improves The
Expression Profile of Growth Differentiation Factor-9 and
Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients
with Polycystic Ovarian Syndrome |
title_fullStr | N-Acetylcysteine Compared to Metformin, Improves The
Expression Profile of Growth Differentiation Factor-9 and
Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients
with Polycystic Ovarian Syndrome |
title_full_unstemmed | N-Acetylcysteine Compared to Metformin, Improves The
Expression Profile of Growth Differentiation Factor-9 and
Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients
with Polycystic Ovarian Syndrome |
title_short | N-Acetylcysteine Compared to Metformin, Improves The
Expression Profile of Growth Differentiation Factor-9 and
Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients
with Polycystic Ovarian Syndrome |
title_sort | n-acetylcysteine compared to metformin, improves the
expression profile of growth differentiation factor-9 and
receptor tyrosine kinase c-kit in the oocytes of patients
with polycystic ovarian syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641458/ https://www.ncbi.nlm.nih.gov/pubmed/29043702 http://dx.doi.org/10.22074/ijfs.2018.5142 |
work_keys_str_mv | AT cheraghiebrahim nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome AT soleimanimehranjanimalek nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome AT shariatzadehseyedmohammadali nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome AT nasresfahanimohammadhossein nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome AT alanibehrang nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome |